These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1981185)

  • 41. Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study.
    Hu XT; Wang RY
    J Neurosci; 1988 Nov; 8(11):4340-8. PubMed ID: 2972814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1989 May; 33(1):41-4. PubMed ID: 2571171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390.
    Starr BS; Starr MS
    Pharmacol Biochem Behav; 1986 Apr; 24(4):837-9. PubMed ID: 2940604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR; Bunney BS
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of dopamine receptor involvement in rat feeding behaviour.
    Zarrindast MR; Owji AA; Hosseini-Nia T
    Gen Pharmacol; 1991; 22(6):1011-6. PubMed ID: 1687390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behavioural effects of selective dopamine D-1 and D-2 agonists and antagonists in guinea-pigs.
    Brent PJ
    Psychopharmacology (Berl); 1991; 104(2):201-7. PubMed ID: 1831560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity.
    Plaznik A; Stefanski R; Kostowski W
    Psychopharmacology (Berl); 1989; 99(4):558-62. PubMed ID: 2594923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of genotype and dopamine receptors in behaviour of inbred mice in a forced swimming test.
    Nikulina EM; Skrinskaya JA; Popova NK
    Psychopharmacology (Berl); 1991; 105(4):525-9. PubMed ID: 1685251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cholecystokinin octapeptide potentiates the inhibitory response mediated by D2 dopamine receptors in slices of the ventral tegmental area of the brain in the rat.
    Stittsworth JD; Mueller AL
    Neuropharmacology; 1990 Feb; 29(2):119-27. PubMed ID: 2184375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK; Jackson DM
    Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ontogenetic differences in the psychopharmacological responses to separate and combined stimulation of D1 and D2 dopamine receptors during the neonatal to weanling age period.
    Moody CA; Spear LP
    Psychopharmacology (Berl); 1992; 106(2):161-8. PubMed ID: 1347951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M; Danek L; Smiałowski A
    Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of dopamine receptors in the occurrence of the behavioral motor disturbances in rats exposed to high pressure.
    Abraini JH; Tomei C; Rostain JC
    Pharmacol Biochem Behav; 1991 Jul; 39(3):773-9. PubMed ID: 1686107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.